Atle Fund Management AB

STOCKHOLM, V7 · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$373.4M2026 Q3
Positions39
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.53.9%

Atle Fund Management AB reported 39 positions worth $373.4M as of September 30, 2026 (13F filed November 12, 2026). Largest holding: LLY (9.7%). Biggest move: exit IONS ($10.9M).

10 / 39 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 LLYEli Lilly$36.1M9.67%31,202——+23.7%
▸ 2 MRKMerck$24.6M6.58%168,987——-0.6%
▸ 3 JNJJohnson & Johnson$24.2M6.48%91,387——+6.7%
▸ 4 ABBVAbbVie$23.9M6.40%91,294——+12.6%
▸ 5 TMOThermo Fisher Scientific$23.2M6.22%34,410——+2.4%
▸ 6 BIIBBiogen$16.0M4.29%70,955——+11.4%
▸ 7 VRTXVertex Pharmaceuticals Inc$14.7M3.94%28,157——+2.9%
▸ 8 RVMDRevolution Medicines$13.6M3.63%66,113——-18.7%
▸ 9 ONCBeOne Medicines$13.1M3.50%35,679——+12.4%
▸ 10 CVSCVS Health$11.9M3.20%139,311——+3.4%

Pro Feature

The remaining 29 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Atle Fund Management AB hold as of Q3 2026?

Atle Fund Management AB reported 39 positions worth $373.4M in its Q3 2026 13F filing. Largest positions: LLY (9.7%), MRK (6.6%), JNJ (6.5%), ABBV (6.4%) and TMO (6.2%).

What did Atle Fund Management AB buy in Q3 2026?

New positions: SMMT, CMPS, PVLA and MANE. Added to: ABBV, VRTX, TMO, INSM and BBIO (18 in all).

What did Atle Fund Management AB sell in Q3 2026?

Reduced: NBIX, ALKS, MRK, MIRM and RVMD (15 in all). Sold out entirely: IONS, BCAX, CMPX and JBIO.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.